Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,400
-700 (-2.49%)
At close: Apr 28, 2026
131.22%
Market Cap 863.32B
Revenue (ttm) 566.93B
Net Income (ttm) 27.66B
Shares Out 31.51M
EPS (ttm) 936.77
PE Ratio 29.25
Forward PE 21.06
Dividend 200.00 (0.71%)
Ex-Dividend Date Mar 30, 2026
Volume 124,817
Average Volume 166,639
Open 27,900
Previous Close 28,100
Day's Range 27,200 - 28,000
52-Week Range 11,340 - 45,050
Beta 1.19
RSI 41.46
Earnings Date May 8, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.